EKF Diagnostics (LON:EKF) Shares Pass Above Two Hundred Day Moving Average – Time to Sell?

Shares of EKF Diagnostics Holdings plc (LON:EKF) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 25.27 and traded as high as GBX 27.40. EKF Diagnostics shares last traded at GBX 26.45, with a volume of 100,751 shares traded.

Analyst Upgrades and Downgrades

Separately, Stifel Nicolaus restated a “buy” rating and set a GBX 35 price objective on shares of EKF Diagnostics in a research report on Wednesday, April 22nd. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat, EKF Diagnostics has a consensus rating of “Buy” and an average target price of GBX 35.

EKF Diagnostics Price Performance

The business’s 50 day moving average is GBX 24.89 and its 200-day moving average is GBX 25.27. The firm has a market capitalization of £113.85 million, a P/E ratio of 56.27 and a beta of 0.49. The company has a quick ratio of 1.77, a current ratio of 4.16 and a debt-to-equity ratio of 2.01.

EKF Diagnostics (LON:EKF) last announced its quarterly earnings data on Tuesday, March 24th. The company reported GBX 0.47 earnings per share (EPS) for the quarter. EKF Diagnostics had a net margin of 4.12% and a return on equity of 3.01%. As a group, sell-side analysts predict that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current fiscal year.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.